Berlin to host 11th IAS Conference on HIV Science in 2021
“HIV remains an important issue on our national and international agenda,” Germany’s Federal Minister of Health, Jens Spahn, said. “To further reduce the spread of HIV, we have made HIV self-testing widely available in Germany and will pass a bill to provide PrEP prescriptions free of charge for people with substantial risk of infection.
“Further research, concerted efforts and innovations are needed to end AIDS by 2030. We will therefore continue to invest in HIV research to find a vaccination and cure for HIV, and we are delighted that the IAS Conference on HIV Science in 2021 will bring together the renowned scientific community in Berlin to share state-of-the-art knowledge that contributes to preventing new HIV infections and to improving the lives of people living with HIV.
Germany is highly regarded for its leadership in HIV research and its capital is also home to the first and only reported case of a sterilizing cure for HIV, commonly known as the “Berlin patient”. German doctor Gero Hütter from the Charité – Universitätsmedizin Berlin treated Timothy Ray Brown, an HIV-positive man, with acute myeloid leukaemia. Hütter led the process of a bone marrow transplant of haematopoietic stem cells from a naturally HIV-resistant donor, and Brown has continued to be free of readily detectable virus in the absence of therapy for 12 years. This case continues to serve as a scientific landmark suggesting that HIV infection might one day be curable.
“We are very proud to host the world’s most influential meeting on HIV research,” the Governing Mayor of Berlin, Michael Müller, said. “It represents Berlin’s commitment to investing in cutting-edge and evidence-based approaches to ensure quality of life and equal access to treatment and prevention services. We look forward to working with the IAS to advance science and research needed for the global fight against HIV/AIDS.”
Joint Statement in advance of the 41st Meeting of the Board of the Global Fund on the eligibility of the Russian Federation for HIV funding within the next allocation periodOn May 15–16, 2019, the Board of the Global Fund will consider the updated allocation methodology for the 2020–2022 allocation period. Eurasian Harm Reduction Association, together with a number of partners, has initiated the preparation and collection of signatures under the NGO’s Joint Statement on the eligibility of the Russian Federation for HIV funding by […] Read more
Interregional workshop in preparation for transitioning towards domestic financing in TB, HIV and Malaria responseThis report is prepared on a workshop, organized jointly by the WHO Regional Office for Europe, WHO headquarters, the Global Fund to Fight AIDS, Tuberculosis and Malaria and the United States Agency for International Development, took place on 17–19 October 2018, in Tbilisi, Georgia. Read more
Assessment of Existence and Use of HIV Packages of Services for Key PopulationsThe Global Fund commissioned an assessment of the design, implementation, utilisation and monitoring of key population HIV Service Packages across 65 countries. Read more
Regional Platform – EECA
This web-resource is a part of new regional communication and coordination project “Regional Civil Society and Community Support, Coordination and Communication Platform - EECA”, implemented by Eurasian Harm Reduction Association (EHRA).
Berlin to host 11th IAS Conference on HIV Science in 2021 28.02.2019 16:37
HIV2020 11.12.2018 16:39
10th IAS Conference on HIV Science (IAS 2019) 04.12.2018 15:37
2nd International Conference on (Re-)Emerging Infectious Diseases 04.12.2018 14:48
HIV & WOMEN 2019 04.12.2018 12:42
INTERNATIONAL VIRAL HEPATITIS ELIMINATION (IVHEM) 2018 04.12.2018 12:27